Medtronic PLC stock falls 1.23% and underperforms competitors
Updated
Updated · MarketWatch · Apr 28
Medtronic PLC stock falls 1.23% and underperforms competitors
11 articles · Updated · MarketWatch · Apr 28
Medtronic PLC shares closed at $81.90 on Tuesday, marking their third consecutive day of losses and finishing 22.98% below the 52-week high of $106.33.
The stock lagged behind rivals, with Johnson & Johnson and Abbott Laboratories both gaining, while Danaher Corp. also declined but less sharply than Medtronic.
Overall market sentiment was negative, as both the S&P 500 and Dow Jones Industrial Average fell, contributing to Medtronic's continued underperformance amid lower-than-average trading volume.
Why did the market punish Medtronic's stock after the company beat its earnings estimates?
Trading far below its peak, is Medtronic a value trap or a major buying opportunity?
With record revenue but shrinking margins, is Medtronic's growth strategy fundamentally flawed?
Are Medtronic's recent acquisitions bold strategic moves or just costly distractions?
After a major cyberattack, how secure are Medtronic's life-saving medical devices?
As GLP-1 drugs reshape diabetes care, can Medtronic's spun-off MiniMed unit survive?